CA1338028C - Antigenes peptidiques synthetiques pour la detection de l'infection a vih-1 - Google Patents

Antigenes peptidiques synthetiques pour la detection de l'infection a vih-1

Info

Publication number: CA1338028C
Authority: CA; Canada
Prior art keywords: hiv; glu; peptide; leu; ser
Prior art date: 1987-03-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA000616876A

Other languages

English (en)

Inventor

Anders Vahlne

Bo Svennerholm

Lars Rymo

Stig Jeansson

Peter Horal

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Syntello AB

Original Assignee

Syntello AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-27

Filing date

1994-06-09

Publication date

1996-01-30

1987-03-27 Priority claimed from SE8701294A external-priority patent/SE468181B/sv

1988-03-25 Priority claimed from CA000562531A external-priority patent/CA1336473C/fr

1994-06-09 Application filed by Syntello AB filed Critical Syntello AB

1994-06-09 Priority to CA000616876A priority Critical patent/CA1338028C/fr

1996-01-30 Application granted granted Critical

1996-01-30 Publication of CA1338028C publication Critical patent/CA1338028C/fr

2008-03-25 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 170
208000031886 HIV Infections Diseases 0.000 title abstract description 9
238000001514 detection method Methods 0.000 title abstract description 8
108091007433 antigens Proteins 0.000 title description 54
102000036639 antigens Human genes 0.000 title description 54
239000000427 antigen Substances 0.000 title description 52
241000713772 Human immunodeficiency virus 1 Species 0.000 claims abstract description 10
239000000203 mixture Substances 0.000 claims abstract description 9
238000004519 manufacturing process Methods 0.000 claims abstract description 7
241001465754 Metazoa Species 0.000 claims abstract description 5
238000000034 method Methods 0.000 claims description 21
150000001413 amino acids Chemical class 0.000 claims description 20
230000000890 antigenic effect Effects 0.000 claims description 20
230000001900 immune effect Effects 0.000 claims description 17
125000003275 alpha amino acid group Chemical group 0.000 claims description 12
230000015572 biosynthetic process Effects 0.000 claims description 10
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
102000004196 processed proteins & peptides Human genes 0.000 abstract description 71
108090000623 proteins and genes Proteins 0.000 abstract description 42
102000004169 proteins and genes Human genes 0.000 abstract description 36
238000003556 assay Methods 0.000 abstract description 13
238000002965 ELISA Methods 0.000 description 43
101800001690 Transmembrane protein gp41 Proteins 0.000 description 34
210000002966 serum Anatomy 0.000 description 33
238000006243 chemical reaction Methods 0.000 description 32
235000018102 proteins Nutrition 0.000 description 32
230000000875 corresponding effect Effects 0.000 description 26
230000009257 reactivity Effects 0.000 description 23
208000030507 AIDS Diseases 0.000 description 20
235000001014 amino acid Nutrition 0.000 description 20
238000012360 testing method Methods 0.000 description 17
241000700605 Viruses Species 0.000 description 14
238000001262 western blot Methods 0.000 description 13
108700004026 gag Genes Proteins 0.000 description 12
206010001513 AIDS related complex Diseases 0.000 description 10
101800005164 Peptide V Proteins 0.000 description 10
101150098622 gag gene Proteins 0.000 description 10
108700004025 env Genes Proteins 0.000 description 8
208000015181 infectious disease Diseases 0.000 description 8
241000282414 Homo sapiens Species 0.000 description 7
210000004369 blood Anatomy 0.000 description 7
239000008280 blood Substances 0.000 description 7
238000003786 synthesis reaction Methods 0.000 description 7
230000003612 virological effect Effects 0.000 description 7
241000713340 Human immunodeficiency virus 2 Species 0.000 description 6
210000004027 cell Anatomy 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 6
101150030339 env gene Proteins 0.000 description 6
108091003079 Bovine Serum Albumin Proteins 0.000 description 5
230000027455 binding Effects 0.000 description 5
229940098773 bovine serum albumin Drugs 0.000 description 5
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
229960005486 vaccine Drugs 0.000 description 5
108010078791 Carrier Proteins Proteins 0.000 description 4
102000014914 Carrier Proteins Human genes 0.000 description 4
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
101710177291 Gag polyprotein Proteins 0.000 description 4
229920001213 Polysorbate 20 Polymers 0.000 description 4
230000008878 coupling Effects 0.000 description 4
238000010168 coupling process Methods 0.000 description 4
238000005859 coupling reaction Methods 0.000 description 4
238000003745 diagnosis Methods 0.000 description 4
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
239000002953 phosphate buffered saline Substances 0.000 description 4
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
238000012216 screening Methods 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
108090000288 Glycoproteins Proteins 0.000 description 3
102000003886 Glycoproteins Human genes 0.000 description 3
108010039918 Polylysine Proteins 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
210000005260 human cell Anatomy 0.000 description 3
229920000656 polylysine Polymers 0.000 description 3
238000000746 purification Methods 0.000 description 3
238000003127 radioimmunoassay Methods 0.000 description 3
239000011347 resin Substances 0.000 description 3
229920005989 resin Polymers 0.000 description 3
-1 sera Substances 0.000 description 3
239000007790 solid phase Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
108010015780 Viral Core Proteins Proteins 0.000 description 2
108010003533 Viral Envelope Proteins Proteins 0.000 description 2
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000003593 chromogenic compound Substances 0.000 description 2
238000010367 cloning Methods 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
230000009918 complex formation Effects 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
238000002405 diagnostic procedure Methods 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000011521 glass Substances 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
238000013507 mapping Methods 0.000 description 2
210000004779 membrane envelope Anatomy 0.000 description 2
QPJSUIGXIBEQAC-UHFFFAOYSA-N n-(2,4-dichloro-5-propan-2-yloxyphenyl)acetamide Chemical compound CC(C)OC1=CC(NC(C)=O)=C(Cl)C=C1Cl QPJSUIGXIBEQAC-UHFFFAOYSA-N 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
125000006239 protecting group Chemical group 0.000 description 2
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
ZQEBQGAAWMOMAI-ZETCQYMHSA-N (2s)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCC[C@H]1C(O)=O ZQEBQGAAWMOMAI-ZETCQYMHSA-N 0.000 description 1
ZYJPUMXJBDHSIF-NSHDSACASA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZYJPUMXJBDHSIF-NSHDSACASA-N 0.000 description 1
IMUSLIHRIYOHEV-ZETCQYMHSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-methylsulfanylbutanoic acid Chemical compound CSCC[C@@H](C(O)=O)NC(=O)OC(C)(C)C IMUSLIHRIYOHEV-ZETCQYMHSA-N 0.000 description 1
QVHJQCGUWFKTSE-YFKPBYRVSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)OC(C)(C)C QVHJQCGUWFKTSE-YFKPBYRVSA-N 0.000 description 1
WXYGVKADAIJGHB-ZDUSSCGKSA-N (2s)-3-(1h-indol-2-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound C1=CC=C2NC(C[C@H](NC(=O)OC(C)(C)C)C(O)=O)=CC2=C1 WXYGVKADAIJGHB-ZDUSSCGKSA-N 0.000 description 1
DCLJSEPKYJSEHW-HNNXBMFYSA-N (2s)-3-[1-(4-methylphenyl)sulfonylimidazol-4-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C=C(C[C@H](NC(=O)OC(C)(C)C)C(O)=O)N=C1 DCLJSEPKYJSEHW-HNNXBMFYSA-N 0.000 description 1
UYWMYJQSTUVRHR-SFHVURJKSA-N (2s)-3-[4-[(2-bromophenyl)methoxycarbonyloxy]phenyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound C1=CC(C[C@H](NC(=O)OC(C)(C)C)C(O)=O)=CC=C1OC(=O)OCC1=CC=CC=C1Br UYWMYJQSTUVRHR-SFHVURJKSA-N 0.000 description 1
SZXBQTSZISFIAO-ZETCQYMHSA-N (2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C SZXBQTSZISFIAO-ZETCQYMHSA-N 0.000 description 1
WBIIPXYJAMICNU-AWEZNQCLSA-N (2s)-5-[amino-[(4-methylphenyl)sulfonylamino]methylidene]azaniumyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate Chemical compound CC1=CC=C(S(=O)(=O)NC(N)=NCCC[C@H](NC(=O)OC(C)(C)C)C(O)=O)C=C1 WBIIPXYJAMICNU-AWEZNQCLSA-N 0.000 description 1
VVNYDCGZZSTUBC-LURJTMIESA-N (2s)-5-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxopentanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CCC(N)=O VVNYDCGZZSTUBC-LURJTMIESA-N 0.000 description 1
CTXPLTPDOISPTE-YPMHNXCESA-N (2s,3r)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxybutanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)[C@@H](C)OCC1=CC=CC=C1 CTXPLTPDOISPTE-YPMHNXCESA-N 0.000 description 1
LXUNZSDDXMPKLP-UHFFFAOYSA-N 2-Methylbenzenethiol Chemical compound CC1=CC=CC=C1S LXUNZSDDXMPKLP-UHFFFAOYSA-N 0.000 description 1
VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 1
208000012124 AIDS-related disease Diseases 0.000 description 1
ITZMJCSORYKOSI-AJNGGQMLSA-N APGPR Enterostatin Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CCC1 ITZMJCSORYKOSI-AJNGGQMLSA-N 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
241000282412 Homo Species 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
FYYSQDHBALBGHX-YFKPBYRVSA-N N(alpha)-t-butoxycarbonyl-L-asparagine Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC(N)=O FYYSQDHBALBGHX-YFKPBYRVSA-N 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
241000765083 Ondina Species 0.000 description 1
101000690429 Panax ginseng Floral homeotic protein AGAMOUS Proteins 0.000 description 1
108010076039 Polyproteins Proteins 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
101000828148 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Transposon Ty3-G Gag polyprotein Proteins 0.000 description 1
101000790437 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Transposon Ty3-I Gag polyprotein Proteins 0.000 description 1
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
206010046865 Vaccinia virus infection Diseases 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
ZAFQHMFHEMVQEB-UHFFFAOYSA-N acetonitrile 2,2,2-trifluoroacetic acid Chemical compound CC#N.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F ZAFQHMFHEMVQEB-UHFFFAOYSA-N 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000009435 amidation Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
239000011324 bead Substances 0.000 description 1
VWYLMMNTUOUYCT-UHFFFAOYSA-N benzyl carbonobromidate Chemical compound BrC(=O)OCC1=CC=CC=C1 VWYLMMNTUOUYCT-UHFFFAOYSA-N 0.000 description 1
HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
239000010836 blood and blood product Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
239000000306 component Substances 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
LJSQFQKUNVCTIA-UHFFFAOYSA-N diethyl sulfide Chemical compound CCSCC LJSQFQKUNVCTIA-UHFFFAOYSA-N 0.000 description 1
KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
230000005802 health problem Effects 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
235000018977 lysine Nutrition 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
QAAQPSNBIGNDII-YDALLXLXSA-N n-cyclohexylcyclohexanamine;(2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxypropanoic acid Chemical compound C1CCCCC1NC1CCCCC1.CC(C)(C)OC(=O)N[C@H](C(O)=O)COCC1=CC=CC=C1 QAAQPSNBIGNDII-YDALLXLXSA-N 0.000 description 1
230000036963 noncompetitive effect Effects 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
101710135378 pH 6 antigen Proteins 0.000 description 1
239000000123 paper Substances 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
IWHCAJPPWOMXNW-LYKMMFCUSA-N peptide t Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)CC1=CC=C(O)C=C1 IWHCAJPPWOMXNW-LYKMMFCUSA-N 0.000 description 1
239000012071 phase Substances 0.000 description 1
RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
230000009145 protein modification Effects 0.000 description 1
239000002516 radical scavenger Substances 0.000 description 1
230000036647 reaction Effects 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
229940031626 subunit vaccine Drugs 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
235000002374 tyrosine Nutrition 0.000 description 1
208000007089 vaccinia Diseases 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Peptides Or Proteins (AREA)

CA000616876A 1987-03-27 1994-06-09 Antigenes peptidiques synthetiques pour la detection de l'infection a vih-1 Expired - Fee Related CA1338028C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000616876A CA1338028C (fr)	1987-03-27	1994-06-09	Antigenes peptidiques synthetiques pour la detection de l'infection a vih-1

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
SE8701294A SE468181B (sv)	1987-03-27	1987-03-27	Hiv-1 gp41 peptid, vaccin och antigen innehaallande peptiden jaemte diagnostiskt test med peptiden
SE8701294-4		1987-03-27
US5172687A	1987-05-18	1987-05-18
US051,726		1987-05-18
CA000562531A CA1336473C (fr)	1987-03-27	1988-03-25	Antigenes peptidiques cycliques pour le depistage de l'infection par le vih-i
CA000616876A CA1338028C (fr)	1987-03-27	1994-06-09	Antigenes peptidiques synthetiques pour la detection de l'infection a vih-1

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000562531A Division CA1336473C (fr)	1987-03-27	1988-03-25	Antigenes peptidiques cycliques pour le depistage de l'infection par le vih-i

Publications (1)

Publication Number	Publication Date
CA1338028C true CA1338028C (fr)	1996-01-30

Family

ID=27167917

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000616876A Expired - Fee Related CA1338028C (fr)	1987-03-27	1994-06-09	Antigenes peptidiques synthetiques pour la detection de l'infection a vih-1

Country Status (1)

Country	Link
CA (1)	CA1338028C (fr)

1994
- 1994-06-09 CA CA000616876A patent/CA1338028C/fr not_active Expired - Fee Related

Legal Events

Date	Code	Title	Description
1999-02-01	MKLA	Lapsed

Publication	Publication Date	Title
EP0292454B1 (fr)	1992-12-09	Antigène peptide synthétique pour la détection d'infections d'HIV-2-
CA1336473C (fr)	1995-07-25	Antigenes peptidiques cycliques pour le depistage de l'infection par le vih-i
CA1336529C (fr)	1995-08-01	Antigenes peptidiques synthetiques pour la detection de l'infection a htlv-1
EP0231914B1 (fr)	1994-08-10	Peptides d'enveloppe de HTLV-III
EP0247557B1 (fr)	1994-04-20	Peptides enveloppé HTLV-III(LAV)
EP0317804B1 (fr)	1995-10-04	Peptides de VIH et méthodes de détection de VIH
AU654240B2 (en)	1994-10-27	A method of eliciting the production of antibodies against HTLV-1 in mammals
EP0326490B1 (fr)	1995-12-13	Peptides synthétiques et leur mélanges pour la détection d'anticorps HIV
JP3390002B2 (ja)	2003-03-24	Ｈｔｌｖ―ｉおよびｈｔｌｖ―ｉｉウイルスに対する抗体を検出するためのペプチドおよびアナログおよびその混合物
US5283320A (en)	1994-02-01	Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom
CA1338028C (fr)	1996-01-30	Antigenes peptidiques synthetiques pour la detection de l'infection a vih-1
GB2236754A (en)	1991-04-17	Peptide fragments of p17 protein of hiv
CA1338001C (fr)	1996-01-23	Antigene peptidiques synthetiques pour la detection de l'in fection par le htlv-1
RU1825424C (ru)	1993-06-30	Способ обнаружени антител к ВИЧ-2
CA1341594C (fr)	2009-04-21	Peptides synthetiques et leur melanges pour la detection d'anticorps contre hiv
JPH0215098A (ja)	1990-01-18	Ｈｉｖ−１感染検出用合成ペプチド杭原、その組成物およびその使用方法
JPH01163198A (ja)	1989-06-27	Ｈｉｖ−２感染検出用合成ペプチド抗原、その組成物およびその使用方法
HK1006921A (en)	1999-03-26	Peptides and antibodies derived therefrom for the diagnosis of , therapy for and vaccination against htlv-1 infection